Association of estrogen receptor-alpha and vitamin D receptor genotypes with therapeutic response to calcium in postmenopausal Chinese women

Acta Pharmacologica Sinica

Volumn 25, Issue 12, 2004, Pages 1690-1697

  Zhang, Zhen Lin ^a   Qin, Yue Juan ^a   Huang, Qi Ren ^a   He, Jin Wei ^a   Li, Miao ^a   Zhou, Qi ^a   Hu, Yun Qiu ^a   Liu, Yu Juan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bone density; Calcitriol receptors; Estrogen receptors; Polymorphism (genetics)

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCICHEW D3; CALCIUM; COLECALCIFEROL; ESTROGEN RECEPTOR ALPHA; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D RECEPTOR;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE TURNOVER; CHINESE; DIET SUPPLEMENTATION; DRUG MIXTURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; POLYMERASE CHAIN REACTION; POSTMENOPAUSE OSTEOPOROSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VITAMIN BLOOD LEVEL;

AGED; ALKALINE PHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; CALCIUM; CHOLECALCIFEROL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PARATHYROID HORMONE; POSTMENOPAUSE; RECEPTORS, CALCITRIOL;

EID: 10344266476     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Nguyen TV, Blangero J, Eisman JA. Genetic epidemiological approaches to the search for osteoporosis gene. J Bone Miner Res 2000; 15: 392-401.
2. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7.
3. Zmuda JM, Cauley JA, Danielson ME, Wolf RL, Ferrell RE. Vitamin D receptor gene polymorphisms, bone turnover, and rates of bone loss in older African-American women. J Bone Miner Res 1997; 12: 1446-52.
4. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996; 11: 306-11.
5. Keen RW, Kelly PJ. Genetic factor in osteoporosis. What are the implication and treatment? Drugs Aging 1997; 11: 333-7.
6. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP. Vitamin D receptor gene polymorphisms and change in lumbar-spine bone mineral density. Lancet 1995; 345: 423-4.
7. Graafmans WC, Lips P, Ooms ME, Van Leeuwen JP, Pols HAP, Uitterlinden AG. The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 1997; 12: 1241-5.
8. Zhao JX, Zhou XY, Meng XW, Liu GY, Xing XP, Liu HC. Polymorphism of vitamin D receptor gene and its association with bone mineral density and osteocalcin in Chinese. Chin Med J 1997; 110: 366-71.
9. Nakamura T. The importance of genetic and nutritional factors in responses to vitamin D and its analogs in osteoporotic patients. Calcif Tissue Int 1997; 60: 119-23.
10. Niu T, Xu X. Candidate genes for osteoporosis. Therapeutic implications. Am J Pharmacogenom 2001; 1: 11-9.
11. Zhang Y, Zhang KX, Wang GL, Huang W, Zhu DL. Angiotensin II type 2 receptor gene polymorphisms and essential hypertension. Acta Pharmacol Sin 2003; 24: 1089-93.
12. Jin W, Liu Y, Sheng HH, Jin L, Shen YY, Hua Q, et al. Single nucleotide polymorphisms in promoter of angiotensin II type receptor gene associated with essential hypertension and coronary heart disease in Chinese population. Acta Pharmacol Sin 2003; 24: 1083-8.
13. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Ebert S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1991; 80: 706-10.
14. Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, et al. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998; 13: 695-705.
15. Qin YJ, Shen H, Huang QR, Zhao LJ, Zhou Q, Miao XL, et al. Estrogen receptor α gene polymorphisms and peak bone density in Chinese nuclear families. J Bone Mineral Res 2003; 18: 1028-35.
16. Qin YJ, Zhang ZL, Huang QR, He JW, Hu YQ, Zhou Q, et al. Association of vitamin D receptor and estrogen receptor-α gene polymorphism with peak bone mass and bone size in Chinese women. Acta Pharmacol Sin 2004; 25: 462-8.
17. Johnson JA, Lima JJ. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges. Pharmacogenetics 2003; 13: 525-34.
18. Liu JM, Zhu HM, Zhu XY, Dai M, Jiang L, Xu MY, et al. Estrogen receptor gene polymorphisms and bone mineral density in Chinese postmenopausal women. Chin Med J 2003; 116: 364-7.
19. Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Saarikoski S, et al. Early postmenopausal bone loss is associated with pvu II estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Mineral Res 2000; 15: 315-21.
20. Ferrari S, Rizzoli R, Slosman D, Eisman JA, Bonjour JP. Vitamin D receptor gene polymorphisms and change in lumbar spine bone mineral density. Lancet 1995; 345: 123-4.
21. Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN, Shapses SA. Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Mineral Res 1998; 13: 1045-50.
22. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993; 328: 460-4.